These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18421545)

  • 1. Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus.
    Chung CP; Oeser A; Raggi P; Solus JF; Avalos I; Linton MF; Fazio S; Stein CM
    Clin Rheumatol; 2008 Oct; 27(10):1227-33. PubMed ID: 18421545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
    Chung CP; Oeser A; Raggi P; Sokka T; Pincus T; Solus JF; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2010 Aug; 37(8):1633-8. PubMed ID: 20516025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus.
    Gonzàlez M; Ribalta J; Vives G; Iftimie S; Ferré R; Plana N; Guardiola M; Dallinga-Thie G; Masana L; Castro A
    J Rheumatol; 2010 Nov; 37(11):2259-67. PubMed ID: 20682673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.
    Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
    Scand J Rheumatol; 2009; 38(3):184-9. PubMed ID: 19165647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
    Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM
    Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Asanuma Y; Chung CP; Oeser A; Shintani A; Stanley E; Raggi P; Stein CM
    J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.
    Ormseth MJ; Swift LL; Fazio S; Linton MF; Raggi P; Solus JF; Oeser A; Bian A; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2013 Jan; 22(1):26-33. PubMed ID: 23060481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    Durcan L; Winegar DA; Connelly MA; Otvos JD; Magder LS; Petri M
    J Rheumatol; 2016 Apr; 43(4):745-50. PubMed ID: 26834214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus.
    Olusi SO; George S
    Vasc Health Risk Manag; 2011; 7():75-80. PubMed ID: 21415920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
    Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.